Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

[Tocilizumab in rheumatoid arthritis].

Rueda Gotor J, Blanco Alonso R.

Reumatol Clin. 2011 Mar;6S3:S29-32. doi: 10.1016/j.reuma.2011.01.001. Review. Spanish.

2.

Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

McLaughlin M, Östör A.

Expert Opin Drug Saf. 2015 Mar;14(3):429-37. doi: 10.1517/14740338.2015.998198. Review.

PMID:
25553607
3.
6.

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.

Navarro-Millán I, Singh JA, Curtis JR.

Clin Ther. 2012 Apr;34(4):788-802.e3. doi: 10.1016/j.clinthera.2012.02.014. Review.

7.

Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.

Song SN, Yoshizaki K.

Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):307-16. doi: 10.1517/17425255.2015.992779. Review.

PMID:
25491492
8.

Subcutaneous tocilizumab for the treatment of rheumatoid arthritis.

Mitchell E, Jones G.

Expert Rev Clin Immunol. 2016;12(2):103-14. doi: 10.1586/1744666X.2016.1127159.

PMID:
26629984
10.

Tocilizumab in the treatment of rheumatoid arthritis and beyond.

Shetty A, Hanson R, Korsten P, Shawagfeh M, Arami S, Volkov S, Vila O, Swedler W, Shunaigat AN, Smadi S, Sawaqed R, Perkins D, Shahrara S, Sweiss NJ.

Drug Des Devel Ther. 2014 Mar 28;8:349-64. doi: 10.2147/DDDT.S41437. Review.

11.

[Tocilizumab].

Amano K.

Nihon Rinsho. 2013 Jul;71(7):1238-42. Review. Japanese.

PMID:
23961673
12.

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

Maini RN, Taylor PC, Szechinski J, Pavelka K, Bröll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, Thomson D, Kishimoto T; CHARISMA Study Group..

Arthritis Rheum. 2006 Sep;54(9):2817-29. Erratum in: Arthritis Rheum. 2008 Mar;58(3):887.

13.

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA).

Bingham CO 3rd, Rizzo W, Kivitz A, Hassanali A, Upmanyu R, Klearman M.

Ann Rheum Dis. 2015 May;74(5):818-22. doi: 10.1136/annrheumdis-2013-204427.

14.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.

Mori S, Ueki Y, Akeda Y, Hirakata N, Oribe M, Shiohira Y, Hidaka T, Oishi K.

Ann Rheum Dis. 2013 Aug;72(8):1362-6. doi: 10.1136/annrheumdis-2012-202658.

15.

Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.

Narváez J, Díaz-Torné C, Magallares B, Hernández MV, Reina D, Corominas H, Sanmartí R, de la Serna AR, Llobet JM, Nolla JM.

PLoS One. 2015 Apr 1;10(4):e0123392. doi: 10.1371/journal.pone.0123392.

16.

Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.

Ducreux J, Durez P, Galant C, Nzeusseu Toukap A, Van den Eynde B, Houssiau FA, Lauwerys BR.

Arthritis Rheumatol. 2014 Jan;66(1):15-23. doi: 10.1002/art.38202.

17.

Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis.

Gómez-Reino J.

Rheumatology (Oxford). 2012 Jul;51 Suppl 5:v31-7. doi: 10.1093/rheumatology/kes116. Review.

PMID:
22718925
18.

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.

Smolen JS, Schoels MM, Nishimoto N, Breedveld FC, Burmester GR, Dougados M, Emery P, Ferraccioli G, Gabay C, Gibofsky A, Gomez-Reino JJ, Jones G, Kvien TK, Murakami M, Betteridge N, Bingham CO 3rd, Bykerk V, Choy EH, Combe B, Cutolo M, Graninger W, Lanas A, Martin-Mola E, Montecucco C, Ostergaard M, Pavelka K, Rubbert-Roth A, Sattar N, Scholte-Voshaar M, Tanaka Y, Trauner M, Valentini G, Winthrop KL, de Wit M, van der Heijde D.

Ann Rheum Dis. 2013 Apr;72(4):482-92. doi: 10.1136/annrheumdis-2012-202469.

19.

Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.

Patel AM, Moreland LW.

Drug Des Devel Ther. 2010 Oct 1;4:263-78. doi: 10.2147/DDDT.S14099. Review.

20.

[Inhibition of interleukin 6, a new therapeutic option in rheumatoid arthritis].

Blanco Alonso R, Agudo Bilbao M.

Reumatol Clin. 2009 May-Jun;5(3):121-7. doi: 10.1016/j.reuma.2009.02.001. Spanish.

Supplemental Content

Support Center